Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck.

Source:http://linkedlifedata.com/resource/pubmed/id/16213107

Int. J. Radiat. Oncol. Biol. Phys. 2006 Jan 1 64 1 83-9

Download in:

View as

General Info

PMID
16213107